Ceo
CurrentDandelion Science is a Generative Neuromodulation™ company, committed to advancing precision therapies for vision and brain disorders. Led by a world-class team, Dandelion’s mission is to enhance the lives of people affected by these conditions through the integration of advanced generative technologies and deep scientific expertise. The company has a strategic co-development partnership with the Wyss Center for Bio and Neuroengineering, a research collaboration with the Swiss Federal Institute of Technology, boasts extensive intellectual property, and has received prestigious funding from the US National Institutes of Health and the Swiss Innovation Agency.